Clinical Trials Browser

Phase 2 × Enrolling by invitation × Nivolumab × Clear all

NCT07542262 2026-04-21

NIVO402025

Phase 2 Enrolling by invitation

Gastrointestinal

Stomach Neoplasms, Colorectal Neoplasms

NCT06931613 2025-04-17

Autologous Hematopoietic Stem Cell Transplantation in Pediatric Relapsed or Refractory Hodgkin Lymphoma After Nivolumab Treatment

Phase 2 Enrolling by invitation

Hodgkin Disease, Recurrence